Bionano Genomics - M&A Summary and Business Overview

Life ScienceCompany

Bionano Genomics M&A Summary

Bionano Genomics has acquired 3 companies, including 3 in the last 5 years. A total of 1 acquisition came from private equity firms.

Bionano Genomics has acquired in 2 different US states. The Company’s most targeted sectors include life science (67%) and software (34%).

Bionano Genomics Business Overview

Where is Bionano Genomics headquartered?

Bionano Genomics is headquartered in San Diego, California.

What is Bionano Genomics’ revenue?

Bionano Genomics disclosed revenue of 36M USD for 2023 and 28M USD for 2022.

How many employees does Bionano Genomics have?

Bionano Genomics has 344 employees.

What sector is Bionano Genomics in?

Bionano Genomics is a life science company.

When was Bionano Genomics founded?

Bionano Genomics was founded in 2003.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1
  • M&A Advisors 1

Bionano Genomics

Bionano Genomics, Inc.

9540 Towne Centre Drive, Suite 100,
San Diego, California 92121
United States,
(858) 888 7600
www.bionano.com

Bionano Genomics is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. Bionano’s Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents, and a suite of data analysis tools, and genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. Bionano Genomics was incorporated in 2003 and is based in San Diego, California.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.6/yr) # - 1 1 1 - - 3
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Purigen Biosystems, Inc. 2022-11-28 - Add-on Acquisition
Pleasanton, California · www.purigenbio.com
BioDiscovery, Inc. 2021-10-12 - Add-on Acquisition
El Segundo, California · www.biodiscovery.com
Lineagen, Inc. 2020-08-24 - Add-on Acquisition
Salt Lake City, Utah · www.lineagen.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (67%) - - -
Software 1 (33%) - - -
Total 3 - - -

By Geo

State/Country Buy Value Sell Value
United States 3 - - -
  California 2 - - -
  Utah 1 - - -
Total 3 - - -

Top M&A Advisors

Financial Deals
Cowen Group, Inc.
1

M&A Connections

Deals
Acquired from
Investor(s)
33%
1 (33%)

 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.